Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Intravenous Iron Supplement for Iron Deficiency in Cardiac Transplant Recipients

Next Previous
Trial Profile

Intravenous Iron Supplement for Iron Deficiency in Cardiac Transplant Recipients

Status: Completed
Phase of Trial: Phase II/III

Latest Information Update: 13 May 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ferric derisomaltose (Primary)
  • Indications Iron deficiency anaemia
  • Focus Therapeutic Use
  • Acronyms IronIC

    • Most Recent Events

    • 09 May 2022 Results of an analysis assessed the determinants of iron status in the 102 IronIC participants to better define iron deficiency in the HTx population published in the Clinical Transplantation
    • 28 Apr 2021 Results assessing the prespecified secondary outcome health related quality of life (HRQoL) in Iron deficient Heart transplant recipients receiving intravenous ferric derisomaltose, presented at the 41st Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation.
    • 23 Jan 2021 Primary endpoint (Peak oxygen consumption) has not been met, as per results published in the Journal of Heart and Lung Transplantation
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top